SMid Cap Biotech Analyst Rama holds a conference call with CEO Fordyce on April 16 at 1 pm hosted by JPMorgan. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
- Evercore expects Vera Therapeutics to trade up on Alpine acquisition news
- Vera Therapeutics price target raised to $56 from $27 at Guggenheim
- Vera Therapeutics price target raised to $34 from $21 at Wedbush
- Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results